journal
MENU ▼
Read by QxMD icon Read
search

Journal of Urology

journal
https://www.readbyqxmd.com/read/28917936/editorial-comment
#1
Luigi Mearini
No abstract text is available yet for this article.
September 13, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28916274/do-urinary-cystine-parameters-predict-clinical-stone-activity
#2
Justin I Friedlander, Jodi A Antonelli, Noah E Canvasser, Monica S C Morgan, Daniel Mollengarden, Sara Best, Margaret S Pearle
PURPOSE: An accurate urinary predictor of stone recurrence would be clinically advantageous for patients with cystinuria. A proprietary assay from Litholink® (Chicago, IL) measures cystine capacity as a potentially more reliable estimate of stone-forming propensity. The recommended capacity level to prevent stone formation, >150 mg/L, has not been directly correlated with clinical stone activity. Herein we investigated the relationship between urinary cystine parameters and clinical stone activity...
September 12, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28916273/identification-of-recurrence-sites-following-post-prostatectomy-treatment-for-prostate-cancer-using-11-c-choline-positron-emission-tomography-and-multiparametric-pelvic-mri
#3
Avinash Nehra, William P Parker, Rimki Haloi, Sean S Park, Lance A Mynderse, Val J Lowe, Brian J Davis, J Fernando Quevedo, Geoffrey B Johnson, Eugene D Kwon, R Jeffrey Karnes
PURPOSE: To describe anatomic sites of recurrence among prostate cancer patients with biochemical recurrence following radical prostatectomy (RP) and postoperative radiotherapy (RT) and/or androgen deprivation therapy (ADT) using (11)C-Choline PET/CT and multiparametric-MRI. MATERIALS AND METHODS: RP patients evaluated with (11)C-Choline PET/CT and multiparametric-MRI following RT and/or ADT were evaluated for patterns of recurrence and clinicopathologic features...
September 12, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28916242/erratum
#4
(no author information available yet)
No abstract text is available yet for this article.
September 12, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28899769/incidence-and-predictors-of-complications-due-to-urethral-stricture-in-patients-awaiting-urethroplasty
#5
Nathan Y Hoy, David W Chapman, Nicholas Dean, Keith F Rourke
PURPOSE: The purpose of this study is to examine the incidence and predictors of complications due to urethral stricture in patients awaiting urethroplasty. METHODS AND METHODS: A retrospective chart review of patients undergoing urethroplasty from 2009-2013 was performed. The primary outcome was complications, defined as any unplanned interaction with the health care system due to the urethral stricture during the period between decision for surgery and urethroplasty...
September 9, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28899768/missed-opportunities-to-decrease-radiation-exposure-in-children-with-renal-trauma
#6
Thomas W Gaither, Mohannad A Awad, Natalia V Leva, Gregory P Murphy, Benjamin N Breyer, Hillary L Copp
BACKGROUND: Efforts have been made to reduce computed tomography (CT) scans in children with blunt abdominal injury. CT scans may be over utilized in pediatric patients with renal trauma. METHODS: We performed a retrospective chart review of all renal trauma cases (<18 years old) in two urban trauma centers from 2002-2016. We collected patient demographic and clinical characteristics, renal trauma grades, urologic interventions, and the timing and utilization of CT scans and renal ultrasounds...
September 9, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28890392/natural-history-and-predictors-of-parastomal-hernia-after-robot-assisted-radical-cystectomy-and-ileal-conduit-urinary-diversion
#7
Ahmed A Hussein, Youssef E Ahmed, Paul May, Taimoor Ali, Basim Ahmad, Sana Raheem, Kevin Stone, Adam Hasasnah, Omer Rana, Adam Cole, Derek Wang, Peter Loud, Khurshid A Guru
INTRODUCTION: We investigated the prevalence, variables associated with parastomal hernia (PSH), and its outcomes of after robot-assisted radical cystectomy (RARC) and ileal conduit (IC) for bladder cancer. METHODS: Retrospective review of RARC at our institution was conducted. PSH was defined as protrusion of abdominal contents through the stoma defect in the abdominal wall on cross sectional imaging. PSH was further described in terms of patient and hernia characteristics, symptoms, management and outcomes...
September 7, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28888676/editorial-comment
#8
Saul P Greenfield
No abstract text is available yet for this article.
September 7, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28888773/reply-by-authors
#9
(no author information available yet)
No abstract text is available yet for this article.
September 6, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28888772/re-magnetic-resonance-imaging-underestimation-of-prostate-cancer-geometry-use-of-patient-specific-molds-to-correlate-images-with-whole-mount-pathology-a-priester-s-natarajan-p-khoshnoodi-d-j-margolis-s-s-raman-r-e-reiter-j-huang-w-grundfest-and-l-s-marks-j
#10
LETTER
https://www.readbyqxmd.com/read/28886350/editorial-comment
#11
Thomas M Wheeler
No abstract text is available yet for this article.
September 5, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28886349/this-month-in-pediatric-urology
#12
Mark P Cain
No abstract text is available yet for this article.
September 5, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28886348/personalized-treatment-of-vesicoureteral-reflux-where-are-we-now
#13
EDITORIAL
Saul P Greenfield
No abstract text is available yet for this article.
September 5, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28886347/editorial-comment
#14
J Joy Lee
No abstract text is available yet for this article.
September 5, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28882404/health-related-quality-of-life-following-radical-cystectomy-comparative-analysis-from-the-medicare-health-outcomes-study
#15
Brian R Winters, Jonathan L Wright, Sarah K Holt, Atreya Dash, John L Gore, George R Schade
PURPOSE: Health related quality of life (HRQOL) after radical cystectomy (RC) and ileal conduit is not well quantified at the population level. We evaluated HRQOL in patients with bladder cancer (BC) compared with non-cancer controls (NCC) and colorectal cancer (CRC) patients using SEER-Medicare Health Outcomes Survey (MHOS) data. MATERIALS AND METHODS: SEER-MHOS data (1998-2013) was used to identify patients with BC and CRC undergoing extirpative surgery with ileal conduit or colostomy creation...
September 4, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28870862/incidence-clinicopathologic-risk-factors-management-and-outcomes-of-non-muscle-invasive-recurrences-after-complete-response-to-tri-modality-therapy-for-muscle-invasive-bladder-cancer
#16
Alejandro Sanchez, Matthew F Wszolek, Andrzej Niemierko, Rebecca H Clayman, Michael Drumm, Dayron Rodríguez, Adam S Feldman, Douglas M Dahl, Niall M Heney, William U Shipley, Anthony L Zietman, Jason A Efstathiou
PURPOSE: To describe the incidence, clinicopathologic risk factors, management, and outcomes of non-muscle invasive bladder cancer (NMIBC) recurrences after complete response (CR) to tri-modality therapy (TMT) for muscle-invasive bladder cancer (MIBC). MATERIALS AND METHODS: Patients with cT2-4aN0M0 MIBC (n=342) and CR after TMT were reviewed retrospectively (1986-2013). Using competing risks analyses, the association between baseline clinicopathologic variables and NMIBC outcomes was examined...
September 1, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28870861/sleep-problems-are-associated-with-development-and-progression-of-lower-urinary-tract-symptoms-luts-results-from-reduce
#17
Brandee L Branche, Lauren E Howard, Daniel M Moreira, Claus Roehrborn, Ramiro Castro-Santamaria, Gerald L Andriole, Martin L Hopp, Stephen J Freedland
INTRODUCTION: Though LUTS and sleep problems often co-occur, whether sleep disturbances are linked with LUTS development and progression is unknown. We examined the relationship between sleep problems measured by the Medical Outcomes Study Sleep Scale (MOS-Sleep) 6-item survey and LUTS development and progression in the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study. METHODS: REDUCE was a randomized trial testing prostate cancer chemoprevention with dustasteride in men with PSA 2...
September 1, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28870860/does-early-psadt-epsadt-after-radical-prostatectomy-calculated-prior-to-psa-recurrence-correlate-with-prostate-cancer-outcomes-a-report-from-the-search-database-group
#18
Anna E Teeter, Kagan Griffin, Lauren E Howard, William J Aronson, Martha K Terris, Christopher J Kane, Christopher L Amling, Matthew R Cooperberg, Stephen J Freedland
PURPOSE: Short PSA doubling time (PSADT) following recurrence after radical prostatectomy (RP) portends a poor prognosis. PSADT is traditionally calculated using PSA values >0.2ng/ml. We determined if early PSADT (ePSADT), calculated from the first detectable post-operative PSA up to and including the first recurrence value, correlates with prostate cancer outcomes. METHODS: Cox models were used to examine the association between ePSADT and castration-resistant prostate cancer (CRPC), metastases, all-cause mortality (ACM), and prostate-cancer specific mortality (PCSM) in 674 men who underwent RP between 1988 and 2014...
September 1, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28869809/editorial-comment
#19
Stuart B Bauer
No abstract text is available yet for this article.
September 1, 2017: Journal of Urology
https://www.readbyqxmd.com/read/28867562/long-term-anti-tumor-activity-and-safety-of-enzalutamide-monotherapy-in-hormone-na%C3%A3-ve-prostate-cancer-3-year-open-label-follow-up-results
#20
Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik Van Poppel, Axel Heidenreich, Peter Iversen, Johan Braeckman, Jiri Heracek, Benoit Baron, Andrew Krivoshik, Mohammad Hirmand, Matthew R Smith
PURPOSE: A phase 2 study of enzalutamide monotherapy in patients with hormone-naïve prostate cancer demonstrated high prostate-specific antigen response rates at 25 weeks, 1 year and 2 years, with minimal effects on total body bone mineral density and favorable safety. This follow-up analysis evaluated enzalutamide's anti-tumor activity and safety at 3 years. MATERIALS AND METHODS: Sixty-seven patients with hormone-naïve prostate cancer and non-castrate testosterone (≥230 ng/dL) received enzalutamide 160 mg/day orally until disease progression or unacceptable toxicity in a single-arm analysis...
August 31, 2017: Journal of Urology
journal
journal
23888
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"